The Cost-Effectiveness of Dextranomer/Hyaluronic Acid Copolymer for the Management of Vesicoureteral Reflux. 2. Reflux Correction at the Time of Diagnosis as a Substitute for Traditional Management

Journal of Urology

Volumn 176, Issue 6, 2006, Pages 2649-2653

  Benoit, Ronald M ^a   Peele, Pamela B ^a   Cannon Jr , Glenn M ^a   Docimo, Steven G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

costs and cost analysis; dextranomer hyaluronic acid copolymer; vesico ureteral reflux

Indexed keywords

COPOLYMER; DEXTRANOMER; HYALURONIC ACID;

ARTICLE; CAREGIVER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HUMAN; MORBIDITY; PRIORITY JOURNAL; TREATMENT OUTCOME; VESICOURETERAL REFLUX;

ADJUVANTS, IMMUNOLOGIC; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DEXTRANS; HUMANS; HYALURONIC ACID; INJECTIONS; MODELS, ECONOMIC; PENNSYLVANIA; REPLANTATION; RETREATMENT; URETER; VESICO-URETERAL REFLUX;

EID: 33750504626     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.08.054     Document Type: Article

References (11)

1. Kobelt G., Canning D.A., Hansle T.W., and Lackgren G. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 169 (2003) 1480
2. Kirsch A.J., Perez-Brayfield M.R., and Scherz H.C. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospital of Atlanta experience. J Urol 170 (2003) 211
3. Mathews R., Naslund M., and Docimo S.G. Cost analysis of the treatment of vesicoureteral reflux: a computer model. J Urol 163 (2000) 561
4. Benoit R.M., Wise B.V., Naslund M.J., Mathews R., and Docimo S.G. The effect of dysfunctional voiding on the costs of treating vesicoureteral reflux: a computer model. J Urol 168 (2002) 2173
5. Elder J.S., Diaz M., Caldamone A.A., Cendron M., Greenfield S., Hurwitz R., et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175 (2006) 716
6. Kirsch A.J. Intraluminal ureteral injection (2005) Presented at annual meeting of Society for Pediatric Urology, San Antonio, Texas, May 21
7. Elmore J.M., Scherz H.C., and Kirsch A.J. Dextranomer/hyaluronic acid for vesicoureteral reflux: success rates after initial treatment failure. J Urol 175 (2006) 712
8. Lackgren G., Wahlin N., Skoldenberg E., and Sternberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166 (2001) 1887
9. Oswald J., Riccabona M., Lusuardi L., Bartsch G., and Radmayr C. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology 60 (2002) 894
10. Lavelle M.T., Conlin M.J., and Skoog S.J. Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success. Urology 65 (2005) 564
11. Capozza N., Lais A., Nappo S., and Caione P. The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 172 (2004) 1626